A pooled analysis of more than a quarter of a million adults has found that waist measurements identify elevated cardiovascular risk in many people whose body mass index falls within the normal range. The study, published in the Journal of the American College of Cardiology, examined 259,388 adults across 15 cohort studies followed a median of 20 years.
The finding points to a measurement gap that most people encounter at routine appointments. Weight and height are recorded at nearly every visit, and BMI is calculated automatically. Waist and hip circumference are usually not measured at all.
The practical translation is modest but concrete. A normal BMI does not, by itself, rule out the abdominal fat pattern associated with higher cardiovascular risk, and a tape measure is the only way to check.
The Discordance Between BMI and Waist Measures
Investigators drawn from the Cross-Cohort Collaboration compared waist circumference and waist-to-hip ratio against BMI categories across nine outcomes, including first heart attack, stroke, heart failure, atrial fibrillation, total coronary heart disease, total cardiovascular disease, and all-cause mortality. Participants had no reported history of coronary heart disease at baseline.
Among people classified as normal weight by BMI, 5 percent still had an elevated waist circumference and 18 percent had an elevated waist-to-hip ratio. The mismatch ran the other way, too. Among people classified as having obesity, 9 percent had a low waist circumference and 45 percent had a low waist-to-hip ratio.
Among adults in the normal-weight or overweight BMI range, clinically defined high waist circumference or waist-to-hip ratio was associated with roughly 15-50% greater risk across most of the nine outcomes. Waist circumference data covered 259,351 participants, and waist-to-hip ratio data covered 218,984.
The authors concluded that BMI categories alone can obscure meaningful differences in cardiovascular risk, writing that "relying solely on BMI may result in misclassification of cardiovascular risk." An accompanying editorial noted that the best way to integrate these measures into clinical practice remains unsettled.
The Evidence Behind the Numbers
This was an observational pooled analysis, not a trial. It describes associations between body measurements and later cardiovascular events. It does not establish that abdominal fat directly causes those events, nor does it show that reducing waist size lowers risk.
Several limitations deserve attention up front rather than at the end. Body measurements were taken once, at baseline, so changes over two decades of follow-up were not captured. The cohorts lacked data on physical activity, diet, and genetic predisposition to obesity, each of which independently shapes cardiovascular risk.
The full analysis does not establish new clinical thresholds or replace existing risk calculators. It quantifies how often BMI-based and waist-based categories disagree, and what that disagreement tracks with over time. Prevention guidelines have not changed on the basis of this analysis.
Disclosure context also matters. The lead author reported no relevant conflicts of interest. The senior author has served on advisory boards for Novo Nordisk, Eli Lilly, AstraZeneca and other companies with obesity or cardiometabolic products, and one of the editorialists has consulted for Novo Nordisk and served on an advisory board for Roche Diagnostics.
Who Is Most Likely to Be Missed
The people this analysis flags are the ones least likely to trigger a second look. A normal BMI generally means a preventive visit moves on.
Roughly one in five normal-weight adults in the pooled sample had an elevated waist-to-hip ratio, the clearest example of risk a weight-and-height calculation does not capture.
The reverse group is more complicated. Nearly half of participants with obesity by BMI had a low waist-to-hip ratio, but the implications there were narrower than the headline finding. Among people with obesity, a low waist circumference corresponded to lower all-cause mortality risk and no other differences, and for waist-to-hip ratio, the pattern varied by sex, with women in that category still facing higher risk across outcomes than normal-weight women with a low ratio. Neither finding is a reason to disregard BMI, which remains a useful population-level screen.
Body fat distribution also varies by sex, age, and ancestry, and thresholds for elevated waist measures differ across guidelines. That is one reason the measurement is best interpreted with a clinician rather than against a number found online.
Taking the Measurement and What to Do with It
Measuring waist circumference takes seconds, using a flexible tape at the level of the top of the hip bones, at the end of a normal exhale, snug but not compressing the skin. Waist-to-hip ratio divides the waist measurement by the widest measurement around the hips.
The number is not a diagnosis. It is one input that can prompt a broader conversation about blood pressure, cholesterol, blood sugar, and family history.
Anyone whose measurement falls outside standard ranges should bring it to a primary care visit rather than act on it alone, since that is where lipid panels and blood pressure can be reviewed together. A cardiology summary of the analysis has been published for clinicians.
For people without a regular clinician, community health centers and many pharmacy clinics offer basic cardiovascular screening at low cost, and preventive services including blood pressure and cholesterol screening are covered without cost-sharing under many plans. The American College of Cardiology has also reviewed the findings.
Key Questions Answered
What did the study find? Among 259,388 adults followed for a median of 20 years, waist circumference and waist-to-hip ratio identified elevated cardiovascular risk that BMI categories missed, including in people classified as normal weight.
How many normal-weight adults were affected? In this sample, 5 percent of normal-weight participants had an elevated waist circumference and 18 percent had an elevated waist-to-hip ratio.
Does this prove belly fat causes heart disease? No. This is an observational analysis showing associations. It does not establish causation, nor does it show that reducing waist size lowers risk.
Has medical guidance changed? No. The analysis quantifies how often BMI and waist-based measures disagree. It does not create new clinical thresholds or replace existing cardiovascular risk tools.
What were the main limitations? Measurements were taken only at baseline, and the cohorts lacked data on physical activity, diet, and genetic obesity risk, all of which independently affect cardiovascular risk.
How is waist circumference measured? With a flexible tape at the level of the top of the hip bones, at the end of a normal exhale, snug against the skin without compressing it.
What should someone do with the number? Bring it to a clinician alongside blood pressure, cholesterol, blood sugar, and family history rather than interpreting it in isolation.
